| 苏尼替尼治疗46例慢性粒细胞白血病的临床分析 |
| |
| 引用本文： | 周晟.苏尼替尼治疗46例慢性粒细胞白血病的临床分析[J].上海生物医学工程,2011(1):45-46. |
| |
| 作者姓名： | 周晟 |
| |
| 作者单位： | 浙江省兰溪市人民医院; |
| |
| 摘 要： | 目的比较和评价苏尼替尼治疗慢性粒细胞白血病（CML）的临床效果。方法回顾分析近7年来收治我院的46例CML患者的临床诊疗资料,统计其完全缓解（CR）率、生存期及影响因素。结果完全缓解35例,占总病例数的76.09%;部分缓解7例,占15.22%;未缓解4例,占8.69%。统计至2010年12月,五年存活26例,五年生存率56.52%。结论苏尼替尼是早期治疗CML的有效手段,能较为明显的缓解病情,减少并发症的发生率,提高患者的生存率,治疗过程中仍需要患者及其家属的密切配合。
|
| 关 键 词： | 慢性粒细胞白血病 治疗 效果 |
Clinic Analysis on Sunitinib Treatment of 46 Patients with Chronic Myeloid Leukemia |
| |
| Zhou Sheng Zhejiang Province,Lanxi City People's Hospital.Clinic Analysis on Sunitinib Treatment of 46 Patients with Chronic Myeloid Leukemia[J].Shanghai Journal of Biomedical Engineering,2011(1):45-46. |
| |
| Authors: | Zhou Sheng Zhejiang Province Lanxi City People's Hospital |
| |
| Institution: | Zhou Sheng Zhejiang Province,Lanxi City People's Hospital(lanxi,321100) |
| |
| Abstract: | Objective To compare and evaluate sunitinib treatment of chronic myelogenous leukemia(CML) the clinical effect.Methods We reviewed the past 7 years,46 patients admitted to our hospital for clinical treatment of patients with CML data,statistics,the complete remission(CR) rate,survival and influencing factors.Results Complete remission in 35 cases,76.09% of the total number of cases;partial remission in 7 cases,accounting for 15.22%;no relief in 4 cases,accounting for 8.69%.Statistics to December 2010,11 pat... |
| |
| Keywords: | chronic myeloid leukemia treatment effect |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
